Tower Research Capital LLC (Trc) Foghorn Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.29 Billion
  • Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,890 shares of FHTX stock, worth $16,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,890
Previous 2,104 84.89%
Holding current value
$16,221
Previous $9,000 55.56%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$3.52 - $6.16 $6,286 - $11,001
1,786 Added 84.89%
3,890 $14,000
Q4 2024

Feb 13, 2025
BUY
$4.61 - $9.35 $3,148 - $6,386
683 Added 48.06%
2,104 $9,000
Q3 2024

Nov 14, 2024
SELL
$4.8 - $9.99 $41,947 - $87,302
-8,739 Reduced 86.01%
1,421 $13,000
Q2 2024

Aug 13, 2024
BUY
$5.05 - $8.0 $49,318 - $78,128
9,766 Added 2478.68%
10,160 $58,000
Q1 2024

May 15, 2024
SELL
$2.82 - $7.94 $3,195 - $8,996
-1,133 Reduced 74.2%
394 $2,000
Q4 2023

Feb 13, 2024
SELL
$2.94 - $6.76 $9,978 - $22,943
-3,394 Reduced 68.97%
1,527 $9,000
Q3 2023

Nov 14, 2023
BUY
$5.0 - $9.87 $18,460 - $36,440
3,692 Added 300.41%
4,921 $24,000
Q2 2023

Aug 14, 2023
SELL
$5.37 - $8.84 $6,094 - $10,033
-1,135 Reduced 48.01%
1,229 $8,000
Q1 2023

May 09, 2023
BUY
$4.66 - $8.99 $5,181 - $9,996
1,112 Added 88.82%
2,364 $15,000
Q4 2022

Feb 10, 2023
SELL
$5.44 - $9.46 $13,246 - $23,035
-2,435 Reduced 66.04%
1,252 $8,000
Q3 2022

Nov 10, 2022
BUY
$7.52 - $18.01 $13,287 - $31,823
1,767 Added 92.03%
3,687 $31,000
Q2 2022

Aug 15, 2022
BUY
$8.48 - $16.84 $8,700 - $17,277
1,026 Added 114.77%
1,920 $26,000
Q1 2022

May 12, 2022
SELL
$8.87 - $22.1 $7,450 - $18,564
-840 Reduced 48.44%
894 $14,000
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $9,851 - $20,880
913 Added 111.21%
1,734 $39,000
Q3 2021

Nov 15, 2021
SELL
$8.33 - $15.02 $4,814 - $8,681
-578 Reduced 41.32%
821 $11,000
Q2 2021

Aug 16, 2021
SELL
$9.32 - $13.26 $5,293 - $7,531
-568 Reduced 28.88%
1,399 $15,000
Q1 2021

May 17, 2021
BUY
$11.8 - $23.11 $18,042 - $35,335
1,529 Added 349.09%
1,967 $26,000
Q4 2020

Feb 16, 2021
BUY
$15.12 - $25.88 $6,622 - $11,335
438 New
438 $9,000

Others Institutions Holding FHTX

# of Institutions
89
Shares Held
36.7M
Call Options Held
100
Put Options Held
0
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $174M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email